Trial intelligence / Profile preview

Ketamine versus propofol standard care for agitated delirium in mechanically ventilated ICU patients

IRCT20141209020258N124Phase 3Completed

Sponsor
Arak University of Medical Sciences
Start
Jun 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, double-blind trial of ketamine and propofol in delirium (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: ventilator-free time, agitation and 2 more. Started Jun 2018; status: completed.

02

Drugs

ketaminepropofol
03

Conditions

delirium

Beyond the preview

Go deeper on IRCT20141209020258N124.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20141209020258N124.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call